BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6138456)

  • 1. [Use of nadolol in coronary disease].
    Tkaczewski W; Goch JH; Dziekański S
    Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
    Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
    Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
    [No Abstract]   [Full Text] [Related]  

  • 4. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 8. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
    Bichuette HS
    Arq Bras Cardiol; 1984 Dec; 43(6):449-56. PubMed ID: 6152676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 12. [Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
    Becker HJ; Matthäus EJ; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1690-4. PubMed ID: 19897
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nadolol in the preventive treatment of migraine].
    Szczudlik A
    Wiad Lek; 1984 Jul; 37(14):1087-92. PubMed ID: 6151319
    [No Abstract]   [Full Text] [Related]  

  • 14. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 15. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC; Rosenthal J; Stumpe KO
    Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
    [No Abstract]   [Full Text] [Related]  

  • 17. Nadolol (corgard) in severe and resistant hypertension.
    Nontak MA
    Med J Malaysia; 1981 Sep; 36(3):181-5. PubMed ID: 6120443
    [No Abstract]   [Full Text] [Related]  

  • 18. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Freitag FG; Diamond S
    J Am Osteopath Assoc; 1984 Dec; 84(4):343-7. PubMed ID: 6150909
    [No Abstract]   [Full Text] [Related]  

  • 19. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 20. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Ryan RE; Ryan RE; Sudilovsky A
    Panminerva Med; 1982; 24(2):89-94. PubMed ID: 6128710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.